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This patient was later diagnosed with Opitz-Bohring syndrome with pathogenic mutation in ASXL1:c.2197C>T (p.Gln733X). The deletion contains several known X-linked recessive disease genes and is likely lethal in males. The patient, carrier mother and grandmother showed 98% skewing of Xinactivation.
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F AUTS2 (autism susceptibility candidate 2, MIM *607270) was first discovered as a candidate gene when it was found to be disrupted by a balanced translocation in a pair of monozygotic twins with autism, developmental delay and epilepsy. 1 Despite some functional studies indicating its nuclear location, brain expression in various cell types as well as in regions implicated in autism spectrum disorder (ASD) and its potential role in neuronal development, 2-3 exact function of the gene and its pathways are unknown.
We Various aberrations disrupting AUTS2 have been linked to ID, developmental delay and ASD.
In addition, many of the reported patients have had additional manifestations such as epilepsy, microcephaly, facial dysmorphisms and short stature. [4] [5] [6] A recent study reported 24 exonic microdeletions of the gene in patients with variable neuro-developmental features, growth and feeding problems, skeletal abnormalities, and congenital malformations introducing an AUTS2 syndrome. They indicated that dysmorphic features and ID were more pronounced in individuals with 3' deletions because these affect also the alternative transcript of exons 9-19, which is expressed in brain. 4 The finding of the mild phenotype in our family with exon 4 deletion, which is 5' of the alternative transcription start, further supports this genotypephenotype correlation and emphasises mild short stature as a major clinical finding.
Possible regulatory function of AUTS2 is in line with the presence of several protein interaction motifs for SH2, SH3, and WW domains, as well as the existence of numerous phosphorylation sites. 3 Since no functional domains were reported for exon 4, protein interaction motifs and phosphorylation sites were predicted using the eukaryotic linear motif (ELM) databank. 7 Phosphorylation sites were additionally verified using the NetPhosK server. 8 The absence of exon 4 resulting in the deletion of amino acids 209-220 affects a sequence stretch that contains an unusually high number of residues that are predicted to become phosphorylated: S207, S209, S210, S213, S214, T217, and Y219. Interestingly, the spacing of the serine residues meets exactly the preferences for the action of the hierarchical protein kinases CK1 and GSK3. 9 98th centile). Since recurrent 16p11.2 CNVs have been associated with developmental delay, ID, autism, ADHD, seizures, and psychiatric problems and the spectrum of abnormal phenotypes has been expanded to include congenital abnormalities, 12 it is very likely that the duplication is pathogenic in this patient with incomplete penetrance or variable expressivity since the mother's cognition was not formally tested.
patient 48459, 462 kb deletion within NRXN3, paternally inherited (likely pathogenic)
NRXN3 (MIM *600567) encodes neurexin 3 in alpha-and beta isoforms expressed at variable levels throughout the brain. The neurexins are highly expressed in presynaptic terminals and have been shown to have important roles in synaptic cell adhesion and neurotransmitter secretion. 13 CMA revealed a 462 kb paternally inherited deletion encompassing exons 6-12 of the alpha isoform of NRXN3 and reaching very closely to the transcription start of the beta isoform ( Figure S2 ). Sanger sequencing of the gene in the patient revealed no pathogenic mutation.
This boy was referred due to mild learning difficulties, minor motor problems, dilated cardiomyopathy, some facial features and anal atresia. Deletions of NRXN3 have been recently reported in patients with ASD (one de novo, one inherited from the father with borderline autism phenotype, and two inherited from apparently healthy parents) with reduced penetrance and variable expressivity. 14 CNVs of glutamate receptor genes have been associated with ADHD including eight patients out of 2493 with deletions in GRM8 but none in controls. 16 One patient with a paternally inherited 34.7 kb exonic duplication within GRM8 and two maternally inherited intronic
CNVs have been reported among rare CNVs in individuals with ASD. 17 Thus in accordance with the literature findings attention deficit and hyperactivity of the patient could be well explained by GRM8 defect, but additional unidentified familial factors may contribute to his phenotype.
Figure S1. Expression analysis of ACOT7 (isoform ENST00000377855) in cDNA panels from fetal and adult human tissues.
Expression analysis was performed using customized SYBR green qPCR for exons 1 & 2 of ACOT7 (specific for isoform ENST00000377855). Relative expression levels normalized to GAPDH were set into relation to the mean expression value of this isoform in fetal brain. The highest levels were found in adult pancreas, testis, brain, lung, prostate and colon. No expression was detected in peripheral leukocytes. 
